Ritesh International（519097）株式概要リテッシュ・インターナショナル・リミテッドは、インドでステアリン酸およびゴム・PVC産業向け非食用油の製造・販売を行っている。 詳細519097 ファンダメンタル分析スノーフレーク・スコア評価4/6将来の成長0/6過去の実績2/6財務の健全性6/6配当金0/6報酬当社が推定した公正価値より71.2%で取引されている リスク分析過去5年間で収益は年間0.3%減少しました。 Indian市場と比較して、過去 3 か月間の株価の変動が非常に大きい意味のある時価総額がありません ( ₹453M )すべてのリスクチェックを見る519097 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₹Current Price₹48.3260.5% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-796k2b2016201920222025202620282031Revenue ₹2.1bEarnings ₹46.3mAdvancedSet Fair ValueView all narrativesRitesh International Limited 競合他社Polylink Polymers (India)Symbol: BSE:531454Market cap: ₹463.7mSnehaa OrganicsSymbol: NSEI:SNEHAAMarket cap: ₹447.9mSrigee DLMSymbol: BSE:544399Market cap: ₹507.8mRex Sealing and Packing IndustriesSymbol: BSE:543744Market cap: ₹374.8m価格と性能株価の高値、安値、推移の概要Ritesh International過去の株価現在の株価₹48.3252週高値₹78.6952週安値₹25.27ベータ0.241ヶ月の変化-3.38%3ヶ月変化-17.26%1年変化18.72%3年間の変化17.77%5年間の変化4.93%IPOからの変化3,926.67%最新ニュースReported Earnings • May 23Full year 2026 earnings released: EPS: ₹4.23 (vs ₹3.86 in FY 2025)Full year 2026 results: EPS: ₹4.23 (up from ₹3.86 in FY 2025). Revenue: ₹1.67b (up 30% from FY 2025). Net income: ₹36.8m (up 11% from FY 2025). Profit margin: 2.2% (down from 2.6% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.New Risk • May 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 4.8% per year over the past 5 years. Market cap is less than US$10m (₹564.8m market cap, or US$5.86m). Minor Risk High level of debt (44% net debt to equity).Valuation Update With 7 Day Price Move • May 14Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹48.16, the stock trades at a trailing P/E ratio of 9.7x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 12% over the past three years.お知らせ • May 13Ritesh International Limited to Report Q4, 2026 Results on May 21, 2026Ritesh International Limited announced that they will report Q4, 2026 results on May 21, 2026New Risk • Mar 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 4.8% per year over the past 5 years. Market cap is less than US$10m (₹444.3m market cap, or US$4.75m). Minor Risks High level of debt (44% net debt to equity). Share price has been volatile over the past 3 months (7.7% average weekly change).Valuation Update With 7 Day Price Move • Mar 23Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹47.40, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 22% over the past three years.最新情報をもっと見るRecent updatesReported Earnings • May 23Full year 2026 earnings released: EPS: ₹4.23 (vs ₹3.86 in FY 2025)Full year 2026 results: EPS: ₹4.23 (up from ₹3.86 in FY 2025). Revenue: ₹1.67b (up 30% from FY 2025). Net income: ₹36.8m (up 11% from FY 2025). Profit margin: 2.2% (down from 2.6% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.New Risk • May 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 4.8% per year over the past 5 years. Market cap is less than US$10m (₹564.8m market cap, or US$5.86m). Minor Risk High level of debt (44% net debt to equity).Valuation Update With 7 Day Price Move • May 14Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹48.16, the stock trades at a trailing P/E ratio of 9.7x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 12% over the past three years.お知らせ • May 13Ritesh International Limited to Report Q4, 2026 Results on May 21, 2026Ritesh International Limited announced that they will report Q4, 2026 results on May 21, 2026New Risk • Mar 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 4.8% per year over the past 5 years. Market cap is less than US$10m (₹444.3m market cap, or US$4.75m). Minor Risks High level of debt (44% net debt to equity). Share price has been volatile over the past 3 months (7.7% average weekly change).Valuation Update With 7 Day Price Move • Mar 23Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹47.40, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 22% over the past three years.Reported Earnings • Feb 01Third quarter 2026 earnings released: EPS: ₹1.39 (vs ₹1.06 in 3Q 2025)Third quarter 2026 results: EPS: ₹1.39 (up from ₹1.06 in 3Q 2025). Revenue: ₹444.7m (up 14% from 3Q 2025). Net income: ₹11.9m (up 31% from 3Q 2025). Profit margin: 2.7% (up from 2.3% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.お知らせ • Jan 24Ritesh International Limited to Report Q3, 2026 Results on Jan 30, 2026Ritesh International Limited announced that they will report Q3, 2026 results on Jan 30, 2026Valuation Update With 7 Day Price Move • Jan 05Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹72.89, the stock trades at a trailing P/E ratio of 14.3x. Average trailing P/E is 24x in the Chemicals industry in India. Total returns to shareholders of 1.3% over the past three years.Reported Earnings • Nov 11Second quarter 2026 earnings released: EPS: ₹1.24 (vs ₹0.28 in 2Q 2025)Second quarter 2026 results: EPS: ₹1.24 (up from ₹0.28 in 2Q 2025). Revenue: ₹387.5m (up 50% from 2Q 2025). Net income: ₹10.6m (up 340% from 2Q 2025). Profit margin: 2.7% (up from 0.9% in 2Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Nov 07Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹64.83, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 15% over the past three years.お知らせ • Nov 04Ritesh International Limited to Report Q2, 2026 Results on Nov 10, 2025Ritesh International Limited announced that they will report Q2, 2026 results on Nov 10, 2025お知らせ • Oct 03Ritesh International Limited announced that it expects to receive INR 37.9086 million in fundingRitesh International Limited announces a private placement with Ritesh Arora and Rijul Arora to issue 820,000 Equity Shares at a price of INR 46.23 per share for gross proceeds of INR 37,908,600 on October 1, 2025.Valuation Update With 7 Day Price Move • Sep 24Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹48.13, the stock trades at a trailing P/E ratio of 11.7x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 45% over the past three years.Valuation Update With 7 Day Price Move • Sep 02Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₹32.69, the stock trades at a trailing P/E ratio of 7.9x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 64% over the past three years.お知らせ • Aug 25Ritesh International Limited, Annual General Meeting, Sep 19, 2025Ritesh International Limited, Annual General Meeting, Sep 19, 2025, at 11:00 Indian Standard Time. Location: momnabad road, village akbarpura, ahmedgarh, sangrur, punjab 148021, sangrur IndiaValuation Update With 7 Day Price Move • Aug 14Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹28.60, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 55% over the past three years.Reported Earnings • Aug 08First quarter 2026 earnings released: EPS: ₹0.44 (vs ₹0.17 in 1Q 2025)First quarter 2026 results: EPS: ₹0.44 (up from ₹0.17 in 1Q 2025). Revenue: ₹350.5m (up 33% from 1Q 2025). Net income: ₹3.76m (up 162% from 1Q 2025). Profit margin: 1.1% (up from 0.5% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.お知らせ • Aug 02Ritesh International Limited to Report Q1, 2026 Results on Aug 07, 2025Ritesh International Limited announced that they will report Q1, 2026 results on Aug 07, 2025Valuation Update With 7 Day Price Move • May 28Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹42.78, the stock trades at a trailing P/E ratio of 11.1x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 1.5% over the past three years.Reported Earnings • May 22Full year 2025 earnings released: EPS: ₹3.86 (vs ₹0.093 loss in FY 2024)Full year 2025 results: EPS: ₹3.86 (up from ₹0.093 loss in FY 2024). Revenue: ₹1.29b (up 54% from FY 2024). Net income: ₹33.0m (up ₹33.8m from FY 2024). Profit margin: 2.6% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.お知らせ • May 14Ritesh International Limited to Report Q4, 2025 Results on May 21, 2025Ritesh International Limited announced that they will report Q4, 2025 results on May 21, 2025New Risk • May 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹291.6m market cap, or US$3.46m). Minor Risk Share price has been volatile over the past 3 months (8.6% average weekly change).Valuation Update With 7 Day Price Move • Apr 16Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹34.95, the stock trades at a trailing P/E ratio of 23.5x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 1.3% over the past three years.Reported Earnings • Feb 14Third quarter 2025 earnings released: EPS: ₹1.06 (vs ₹0.07 in 3Q 2024)Third quarter 2025 results: EPS: ₹1.06 (up from ₹0.07 in 3Q 2024). Revenue: ₹391.6m (up 124% from 3Q 2024). Net income: ₹9.08m (up ₹8.46m from 3Q 2024). Profit margin: 2.3% (up from 0.4% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance.お知らせ • Feb 06Ritesh International Limited to Report Nine Months, 2025 Results on Feb 13, 2025Ritesh International Limited announced that they will report nine months, 2025 results on Feb 13, 2025Valuation Update With 7 Day Price Move • Nov 12Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹32.19, the stock trades at a trailing P/E ratio of 64.8x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 6.9% over the past three years.Reported Earnings • Nov 06Second quarter 2025 earnings released: EPS: ₹0.28 (vs ₹0.01 in 2Q 2024)Second quarter 2025 results: EPS: ₹0.28 (up from ₹0.01 in 2Q 2024). Revenue: ₹259.1m (up 28% from 2Q 2024). Net income: ₹2.41m (up ₹2.33m from 2Q 2024). Profit margin: 0.9% (up from 0% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.お知らせ • Oct 26Ritesh International Limited to Report Q2, 2025 Results on Nov 05, 2024Ritesh International Limited announced that they will report Q2, 2025 results on Nov 05, 2024お知らせ • Aug 26Ritesh International Limited, Annual General Meeting, Sep 21, 2024Ritesh International Limited, Annual General Meeting, Sep 21, 2024, at 11:00 Indian Standard Time. Location: momnabad road, village akbarpura, ahmedgarh, sangrur, punjab 148021, sangrur IndiaReported Earnings • Aug 10First quarter 2025 earnings released: EPS: ₹0.17 (vs ₹0.15 loss in 1Q 2024)First quarter 2025 results: EPS: ₹0.17 (up from ₹0.15 loss in 1Q 2024). Revenue: ₹264.1m (up 24% from 1Q 2024). Net income: ₹1.43m (up ₹2.72m from 1Q 2024). Profit margin: 0.5% (up from net loss in 1Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance.お知らせ • Aug 02Ritesh International Limited to Report Q1, 2025 Results on Aug 09, 2024Ritesh International Limited announced that they will report Q1, 2025 results on Aug 09, 2024お知らせ • May 25Ritesh International Limited to Report Q4, 2024 Results on May 30, 2024Ritesh International Limited announced that they will report Q4, 2024 results on May 30, 2024Board Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Non-Executive Independent Director Komal Bhalla was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 15Third quarter 2024 earnings released: EPS: ₹0.07 (vs ₹0.098 in 3Q 2023)Third quarter 2024 results: EPS: ₹0.07 (down from ₹0.098 in 3Q 2023). Revenue: ₹175.1m (down 29% from 3Q 2023). Net income: ₹620.0k (down 26% from 3Q 2023). Profit margin: 0.4% (up from 0.3% in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings.お知らせ • Feb 07Ritesh International Limited to Report Q3, 2024 Results on Feb 13, 2024Ritesh International Limited announced that they will report Q3, 2024 results on Feb 13, 2024Recent Insider Transactions • Nov 10Non-Executive Director recently sold ₹478k worth of stockOn the 9th of November, Ritesh Arora sold around 16k shares on-market at roughly ₹30.79 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹2.0m more than they bought in the last 12 months.Reported Earnings • Oct 29Second quarter 2024 earnings released: EPS: ₹0.01 (vs ₹0.59 in 2Q 2023)Second quarter 2024 results: EPS: ₹0.01 (down from ₹0.59 in 2Q 2023). Revenue: ₹203.1m (down 37% from 2Q 2023). Net income: ₹83.0k (down 98% from 2Q 2023). Profit margin: 0% (down from 1.6% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 40% per year, which means it is well ahead of earnings.お知らせ • Oct 19Ritesh International Limited to Report Q2, 2024 Results on Oct 26, 2023Ritesh International Limited announced that they will report Q2, 2024 results on Oct 26, 2023Buying Opportunity • Sep 07Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.5%. The fair value is estimated to be ₹47.24, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 31% over the last 3 years. Meanwhile, the company became loss making.お知らせ • Aug 26Ritesh International Limited, Annual General Meeting, Sep 26, 2023Ritesh International Limited, Annual General Meeting, Sep 26, 2023, at 11:00 Indian Standard Time. Location: Momnabad Road, Village Akbarpura, (Ahmedgarh) Sangrur Punjab India Agenda: To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended on March 31, 2023 including Audited Balance Sheet as at March 31, 2023, the Statement of Profit & Loss and Cash Flow Statement for the year ended on that date along with the Reports of the Auditors and Directors thereon; to consider and approve, with or without modification, the appointment of Mr. Rijul Arora, who retires by rotation and being eligible, offers himself for reappointment; and to discuss other business matters.Reported Earnings • Aug 16First quarter 2024 earnings released: ₹0.15 loss per share (vs ₹1.99 profit in 1Q 2023)First quarter 2024 results: ₹0.15 loss per share (down from ₹1.99 profit in 1Q 2023). Revenue: ₹212.5m (down 57% from 1Q 2023). Net loss: ₹1.29m (down 108% from profit in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 65% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Aug 08Ritesh International Limited to Report Q1, 2024 Results on Aug 14, 2023Ritesh International Limited announced that they will report Q1, 2024 results on Aug 14, 2023Recent Insider Transactions • Jun 02Additional Non-Executive Director recently sold ₹386k worth of stockOn the 1st of June, Ritesh Arora sold around 9k shares on-market at roughly ₹44.48 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth ₹727k. Insiders have been net sellers, collectively disposing of ₹1.5m more than they bought in the last 12 months.Valuation Update With 7 Day Price Move • Jun 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹44.36, the stock trades at a trailing P/E ratio of 36x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 1,265% over the past three years.Reported Earnings • May 27Full year 2023 earnings released: EPS: ₹1.23 (vs ₹4.17 in FY 2022)Full year 2023 results: EPS: ₹1.23 (down from ₹4.17 in FY 2022). Revenue: ₹1.27b (down 9.8% from FY 2022). Net income: ₹10.5m (down 71% from FY 2022). Profit margin: 0.8% (down from 2.5% in FY 2022). Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has increased by 153% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • May 19Ritesh International Limited to Report Q4, 2023 Results on May 25, 2023Ritesh International Limited announced that they will report Q4, 2023 results on May 25, 2023Valuation Update With 7 Day Price Move • Apr 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹55.39, the stock trades at a trailing P/E ratio of 10.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 1,285% over the past three years.Valuation Update With 7 Day Price Move • Apr 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹42.21, the stock trades at a trailing P/E ratio of 8.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 560% over the past three years.Recent Insider Transactions • Mar 08Additional Non-Executive Director recently sold ₹727k worth of stockOn the 6th of March, Ritesh Arora sold around 17k shares on-market at roughly ₹41.57 per share. This transaction amounted to 1.4% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.Valuation Update With 7 Day Price Move • Feb 28Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹49.40, the stock trades at a trailing P/E ratio of 9.5x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 648% over the past three years.Valuation Update With 7 Day Price Move • Feb 09Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₹54.00, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 744% over the past three years.Reported Earnings • Feb 05Third quarter 2023 earnings released: EPS: ₹0.098 (vs ₹0.73 in 3Q 2022)Third quarter 2023 results: EPS: ₹0.098 (down from ₹0.73 in 3Q 2022). Revenue: ₹246.0m (down 32% from 3Q 2022). Net income: ₹840.0k (down 87% from 3Q 2022). Profit margin: 0.3% (down from 1.7% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has increased by 112% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jan 26Ritesh International Ltd to Report Q3, 2023 Results on Feb 02, 2023Ritesh International Ltd announced that they will report Q3, 2023 results at 3:30 PM, Indian Standard Time on Feb 02, 2023Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Non-Executive Independent Director Komal Bhalla was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Nov 11Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₹76.45, the stock trades at a trailing P/E ratio of 13.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 1,811% over the past three years.Reported Earnings • Nov 06Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: ₹322.9m (down 7.4% from 2Q 2022). Net income: ₹5.06m (up 5.0% from 2Q 2022). Profit margin: 1.6% (up from 1.4% in 2Q 2022). The increase in margin was driven by lower expenses.お知らせ • Oct 29Ritesh International Ltd to Report Q2, 2023 Results on Nov 04, 2022Ritesh International Ltd announced that they will report Q2, 2023 results on Nov 04, 2022Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 22% share price decline to ₹87.75, the stock trades at a trailing P/E ratio of 15.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 1,387% over the past three years.Valuation Update With 7 Day Price Move • Sep 13Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹104, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 1,496% over the past three years.Valuation Update With 7 Day Price Move • Aug 25Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹75.75, the stock trades at a trailing P/E ratio of 13x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 1,126% over the past three years.お知らせ • Aug 13Ritesh International Ltd, Annual General Meeting, Sep 16, 2022Ritesh International Ltd, Annual General Meeting, Sep 16, 2022, at 11:00 Indian Standard Time. Location: Momnabad Road, Village Akbarpura, (Ahmedgarh) District Sangrur, Punjab -148021 Ahmednagar India Agenda: To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended on March 31, 2022 including Audited Balance Sheet as at March 31, 2022, the Statement of Profit & Loss and Cash Flow Statement for the year ended on that date along with the Reports of the Auditors and Directors thereon; to consider the appointment of Mr. Rajiv Arora, who retires by rotation and being eligible, offers himself for reappointment; to ratify the remuneration payable to the Cost Auditor (Verma Khushwinder & Co.) for the FY 2022-23; and to consider other matters.お知らせ • Aug 06Ritesh International Ltd to Report Q1, 2023 Results on Aug 12, 2022Ritesh International Ltd announced that they will report Q1, 2023 results at 3:30 PM, Indian Standard Time on Aug 12, 2022Valuation Update With 7 Day Price Move • Jul 26Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹53.75, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 1,180% over the past three years.Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹50.80, the stock trades at a trailing P/E ratio of 12.2x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 719% over the past three years.Valuation Update With 7 Day Price Move • May 19Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹36.10, the stock trades at a trailing P/E ratio of 18.3x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 688% over the past three years.Buying Opportunity • May 11Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 7.2%. The fair value is estimated to be ₹40.94, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 43% over the last 3 years. Meanwhile, the company has become profitable.お知らせ • May 10Ritesh International Ltd to Report Q4, 2022 Results on May 18, 2022Ritesh International Ltd announced that they will report Q4, 2022 results on May 18, 2022Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Non-Executive Independent Director Komal Bhalla was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Mar 08Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹31.85, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 314% over the past three years.Buying Opportunity • Feb 23Now 20% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be ₹37.03, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 43% per annum over the last 3 years. The company has become profitable over the last 3 years.Board Change • Feb 17Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Non-Executive Independent Director Komal Bhalla was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Jan 03Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹38.15, the stock trades at a trailing P/E ratio of 10.3x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 570% over the past three years.Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS ₹0.56 (vs ₹0.45 in 2Q 2021)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2022 results: Revenue: ₹348.5m (up 93% from 2Q 2021). Net income: ₹4.82m (up 26% from 2Q 2021). Profit margin: 1.4% (down from 2.1% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 48% per year, which means it is significantly lagging earnings growth.Board Change • Sep 03Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Additional Non-Executive Independent Director Kajal Rai was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Jul 01Full year 2021 earnings released: EPS ₹2.38 (vs ₹0.36 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹748.8m (up 72% from FY 2020). Net income: ₹20.3m (up ₹17.2m from FY 2020). Profit margin: 2.7% (up from 0.7% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jun 18Investor sentiment deteriorated over the past weekAfter last week's 22% share price decline to ₹46.05, the stock trades at a trailing P/E ratio of 13.7x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 208% over the past three years.Valuation Update With 7 Day Price Move • May 27Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹43.05, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 121% over the past three years.Valuation Update With 7 Day Price Move • May 04Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹37.05, the stock trades at a trailing P/E ratio of 11.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 173% over the past three years.Valuation Update With 7 Day Price Move • Apr 08Investor sentiment improved over the past weekAfter last week's 27% share price gain to ₹28.65, the stock trades at a trailing P/E ratio of 8.5x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 160% over the past three years.Is New 90 Day High Low • Feb 15New 90-day high: ₹14.68The company is up 13% from its price of ₹13.00 on 17 November 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 16% over the same period.Reported Earnings • Feb 12Third quarter 2021 earnings released: EPS ₹2.48 (vs ₹1.07 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹247.6m (up 102% from 3Q 2020). Net income: ₹21.2m (up 132% from 3Q 2020). Profit margin: 8.6% (up from 7.5% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has only increased by 42% per year, which means it is significantly lagging earnings growth.お知らせ • Feb 03Ritesh International Ltd to Report Q3, 2021 Results on Feb 10, 2021Ritesh International Ltd announced that they will report Q3, 2021 results on Feb 10, 2021お知らせ • Dec 13Ritesh International Ltd Announces Appointment of Ritesh Arora as an Additional DirectorRitesh International Ltd. announced that Mr. Ritesh Arora has been appointed by the board as an Additional Director of the company with effect from December 12, 2020.Valuation Update With 7 Day Price Move • Oct 22Market pulls back on stock over the past weekAfter last week's 16% share price decline to ₹11.40, the stock is trading at a trailing P/E ratio of 12.6x, down from the previous P/E ratio of 14.9x. This compares to an average P/E of 15x in the Chemicals industry in India. Total returns to shareholders over the past three years are 171%.Valuation Update With 7 Day Price Move • Oct 17Market pulls back on stock over the past weekAfter last week's 17% share price decline to ₹12.86, the stock is trading at a trailing P/E ratio of 14.2x, down from the previous P/E ratio of 17.1x. This compares to an average P/E of 15x in the Chemicals industry in India. Total returns to shareholders over the past three years are 199%.お知らせ • Oct 13Ritesh International Ltd Announces Retirement of Reeta Challana as an Independent DirectorRitesh International Ltd. announced that at the Annual General Meeting held on September 28, 2020, the shareholders rejected the the resolution of re-appointment of Mrs. Reeta Challana as an independent Director.お知らせ • Oct 02Ritesh International Ltd Appoints Kajal Rai as Additional Director (Independent Director)Ritesh International Ltd. announced that Ms. Kajal Rai has been appointed by the board as an Additional Director (Independent Director of the company with effect from October 1, 2020.Is New 90 Day High Low • Sep 30New 90-day high: ₹13.20The company is up 269% from its price of ₹3.58 on 01 July 2020. The Indian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period.お知らせ • Aug 09Ritesh International Ltd to Report Q1, 2021 Results on Aug 14, 2020Ritesh International Ltd announced that they will report Q1, 2021 results on Aug 14, 2020お知らせ • Jun 20Ritesh International Ltd to Report Q4, 2020 Results on Jun 26, 2020Ritesh International Ltd announced that they will report Q4, 2020 results on Jun 26, 2020株主還元519097IN ChemicalsIN 市場7D-3.3%-1.0%-2.1%1Y18.7%-5.8%-4.6%株主還元を見る業界別リターン: 519097過去 1 年間で-5.8 % の収益を上げたIndian Chemicals業界を上回りました。リターン対市場: 519097過去 1 年間で-4.6 % の収益を上げたIndian市場を上回りました。価格変動Is 519097's price volatile compared to industry and market?519097 volatility519097 Average Weekly Movement11.9%Chemicals Industry Average Movement7.2%Market Average Movement7.1%10% most volatile stocks in IN Market10.2%10% least volatile stocks in IN Market4.7%安定した株価: 519097の株価は、 Indian市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 519097の weekly volatility ( 12% ) は過去 1 年間安定していますが、依然としてIndianの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1981137Ritesh Aroran/aリテッシュ・インターナショナル・リミテッドは、インドでステアリン酸やゴム・PVC産業向け非食用油の製造・販売を行っている。ステアリン酸、脂肪酸、グリセリン、既製衣料製品を提供。旧社名は Sukhchain & Co Ritesh International Limited は 1981 年に設立され、インドの Sangrur に拠点を置く。もっと見るRitesh International Limited 基礎のまとめRitesh International の収益と売上を時価総額と比較するとどうか。519097 基礎統計学時価総額₹452.89m収益（TTM）₹36.77m売上高(TTM)₹1.67b12.3xPER（株価収益率0.3xP/Sレシオ519097 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計519097 損益計算書（TTM）収益₹1.67b売上原価₹1.32b売上総利益₹350.51mその他の費用₹313.74m収益₹36.77m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）3.92グロス・マージン20.99%純利益率2.20%有利子負債／自己資本比率29.8%519097 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/11 08:53終値2026/06/11 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Ritesh International Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • May 23Full year 2026 earnings released: EPS: ₹4.23 (vs ₹3.86 in FY 2025)Full year 2026 results: EPS: ₹4.23 (up from ₹3.86 in FY 2025). Revenue: ₹1.67b (up 30% from FY 2025). Net income: ₹36.8m (up 11% from FY 2025). Profit margin: 2.2% (down from 2.6% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
New Risk • May 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 4.8% per year over the past 5 years. Market cap is less than US$10m (₹564.8m market cap, or US$5.86m). Minor Risk High level of debt (44% net debt to equity).
Valuation Update With 7 Day Price Move • May 14Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹48.16, the stock trades at a trailing P/E ratio of 9.7x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 12% over the past three years.
お知らせ • May 13Ritesh International Limited to Report Q4, 2026 Results on May 21, 2026Ritesh International Limited announced that they will report Q4, 2026 results on May 21, 2026
New Risk • Mar 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 4.8% per year over the past 5 years. Market cap is less than US$10m (₹444.3m market cap, or US$4.75m). Minor Risks High level of debt (44% net debt to equity). Share price has been volatile over the past 3 months (7.7% average weekly change).
Valuation Update With 7 Day Price Move • Mar 23Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹47.40, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 22% over the past three years.
Reported Earnings • May 23Full year 2026 earnings released: EPS: ₹4.23 (vs ₹3.86 in FY 2025)Full year 2026 results: EPS: ₹4.23 (up from ₹3.86 in FY 2025). Revenue: ₹1.67b (up 30% from FY 2025). Net income: ₹36.8m (up 11% from FY 2025). Profit margin: 2.2% (down from 2.6% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
New Risk • May 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 4.8% per year over the past 5 years. Market cap is less than US$10m (₹564.8m market cap, or US$5.86m). Minor Risk High level of debt (44% net debt to equity).
Valuation Update With 7 Day Price Move • May 14Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹48.16, the stock trades at a trailing P/E ratio of 9.7x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 12% over the past three years.
お知らせ • May 13Ritesh International Limited to Report Q4, 2026 Results on May 21, 2026Ritesh International Limited announced that they will report Q4, 2026 results on May 21, 2026
New Risk • Mar 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 4.8% per year over the past 5 years. Market cap is less than US$10m (₹444.3m market cap, or US$4.75m). Minor Risks High level of debt (44% net debt to equity). Share price has been volatile over the past 3 months (7.7% average weekly change).
Valuation Update With 7 Day Price Move • Mar 23Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹47.40, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 22% over the past three years.
Reported Earnings • Feb 01Third quarter 2026 earnings released: EPS: ₹1.39 (vs ₹1.06 in 3Q 2025)Third quarter 2026 results: EPS: ₹1.39 (up from ₹1.06 in 3Q 2025). Revenue: ₹444.7m (up 14% from 3Q 2025). Net income: ₹11.9m (up 31% from 3Q 2025). Profit margin: 2.7% (up from 2.3% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
お知らせ • Jan 24Ritesh International Limited to Report Q3, 2026 Results on Jan 30, 2026Ritesh International Limited announced that they will report Q3, 2026 results on Jan 30, 2026
Valuation Update With 7 Day Price Move • Jan 05Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹72.89, the stock trades at a trailing P/E ratio of 14.3x. Average trailing P/E is 24x in the Chemicals industry in India. Total returns to shareholders of 1.3% over the past three years.
Reported Earnings • Nov 11Second quarter 2026 earnings released: EPS: ₹1.24 (vs ₹0.28 in 2Q 2025)Second quarter 2026 results: EPS: ₹1.24 (up from ₹0.28 in 2Q 2025). Revenue: ₹387.5m (up 50% from 2Q 2025). Net income: ₹10.6m (up 340% from 2Q 2025). Profit margin: 2.7% (up from 0.9% in 2Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Nov 07Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹64.83, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 15% over the past three years.
お知らせ • Nov 04Ritesh International Limited to Report Q2, 2026 Results on Nov 10, 2025Ritesh International Limited announced that they will report Q2, 2026 results on Nov 10, 2025
お知らせ • Oct 03Ritesh International Limited announced that it expects to receive INR 37.9086 million in fundingRitesh International Limited announces a private placement with Ritesh Arora and Rijul Arora to issue 820,000 Equity Shares at a price of INR 46.23 per share for gross proceeds of INR 37,908,600 on October 1, 2025.
Valuation Update With 7 Day Price Move • Sep 24Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹48.13, the stock trades at a trailing P/E ratio of 11.7x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 45% over the past three years.
Valuation Update With 7 Day Price Move • Sep 02Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₹32.69, the stock trades at a trailing P/E ratio of 7.9x. Average trailing P/E is 27x in the Chemicals industry in India. Total loss to shareholders of 64% over the past three years.
お知らせ • Aug 25Ritesh International Limited, Annual General Meeting, Sep 19, 2025Ritesh International Limited, Annual General Meeting, Sep 19, 2025, at 11:00 Indian Standard Time. Location: momnabad road, village akbarpura, ahmedgarh, sangrur, punjab 148021, sangrur India
Valuation Update With 7 Day Price Move • Aug 14Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹28.60, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 55% over the past three years.
Reported Earnings • Aug 08First quarter 2026 earnings released: EPS: ₹0.44 (vs ₹0.17 in 1Q 2025)First quarter 2026 results: EPS: ₹0.44 (up from ₹0.17 in 1Q 2025). Revenue: ₹350.5m (up 33% from 1Q 2025). Net income: ₹3.76m (up 162% from 1Q 2025). Profit margin: 1.1% (up from 0.5% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.
お知らせ • Aug 02Ritesh International Limited to Report Q1, 2026 Results on Aug 07, 2025Ritesh International Limited announced that they will report Q1, 2026 results on Aug 07, 2025
Valuation Update With 7 Day Price Move • May 28Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹42.78, the stock trades at a trailing P/E ratio of 11.1x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 1.5% over the past three years.
Reported Earnings • May 22Full year 2025 earnings released: EPS: ₹3.86 (vs ₹0.093 loss in FY 2024)Full year 2025 results: EPS: ₹3.86 (up from ₹0.093 loss in FY 2024). Revenue: ₹1.29b (up 54% from FY 2024). Net income: ₹33.0m (up ₹33.8m from FY 2024). Profit margin: 2.6% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
お知らせ • May 14Ritesh International Limited to Report Q4, 2025 Results on May 21, 2025Ritesh International Limited announced that they will report Q4, 2025 results on May 21, 2025
New Risk • May 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹291.6m market cap, or US$3.46m). Minor Risk Share price has been volatile over the past 3 months (8.6% average weekly change).
Valuation Update With 7 Day Price Move • Apr 16Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹34.95, the stock trades at a trailing P/E ratio of 23.5x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 1.3% over the past three years.
Reported Earnings • Feb 14Third quarter 2025 earnings released: EPS: ₹1.06 (vs ₹0.07 in 3Q 2024)Third quarter 2025 results: EPS: ₹1.06 (up from ₹0.07 in 3Q 2024). Revenue: ₹391.6m (up 124% from 3Q 2024). Net income: ₹9.08m (up ₹8.46m from 3Q 2024). Profit margin: 2.3% (up from 0.4% in 3Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 06Ritesh International Limited to Report Nine Months, 2025 Results on Feb 13, 2025Ritesh International Limited announced that they will report nine months, 2025 results on Feb 13, 2025
Valuation Update With 7 Day Price Move • Nov 12Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹32.19, the stock trades at a trailing P/E ratio of 64.8x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 6.9% over the past three years.
Reported Earnings • Nov 06Second quarter 2025 earnings released: EPS: ₹0.28 (vs ₹0.01 in 2Q 2024)Second quarter 2025 results: EPS: ₹0.28 (up from ₹0.01 in 2Q 2024). Revenue: ₹259.1m (up 28% from 2Q 2024). Net income: ₹2.41m (up ₹2.33m from 2Q 2024). Profit margin: 0.9% (up from 0% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.
お知らせ • Oct 26Ritesh International Limited to Report Q2, 2025 Results on Nov 05, 2024Ritesh International Limited announced that they will report Q2, 2025 results on Nov 05, 2024
お知らせ • Aug 26Ritesh International Limited, Annual General Meeting, Sep 21, 2024Ritesh International Limited, Annual General Meeting, Sep 21, 2024, at 11:00 Indian Standard Time. Location: momnabad road, village akbarpura, ahmedgarh, sangrur, punjab 148021, sangrur India
Reported Earnings • Aug 10First quarter 2025 earnings released: EPS: ₹0.17 (vs ₹0.15 loss in 1Q 2024)First quarter 2025 results: EPS: ₹0.17 (up from ₹0.15 loss in 1Q 2024). Revenue: ₹264.1m (up 24% from 1Q 2024). Net income: ₹1.43m (up ₹2.72m from 1Q 2024). Profit margin: 0.5% (up from net loss in 1Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance.
お知らせ • Aug 02Ritesh International Limited to Report Q1, 2025 Results on Aug 09, 2024Ritesh International Limited announced that they will report Q1, 2025 results on Aug 09, 2024
お知らせ • May 25Ritesh International Limited to Report Q4, 2024 Results on May 30, 2024Ritesh International Limited announced that they will report Q4, 2024 results on May 30, 2024
Board Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Non-Executive Independent Director Komal Bhalla was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 15Third quarter 2024 earnings released: EPS: ₹0.07 (vs ₹0.098 in 3Q 2023)Third quarter 2024 results: EPS: ₹0.07 (down from ₹0.098 in 3Q 2023). Revenue: ₹175.1m (down 29% from 3Q 2023). Net income: ₹620.0k (down 26% from 3Q 2023). Profit margin: 0.4% (up from 0.3% in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings.
お知らせ • Feb 07Ritesh International Limited to Report Q3, 2024 Results on Feb 13, 2024Ritesh International Limited announced that they will report Q3, 2024 results on Feb 13, 2024
Recent Insider Transactions • Nov 10Non-Executive Director recently sold ₹478k worth of stockOn the 9th of November, Ritesh Arora sold around 16k shares on-market at roughly ₹30.79 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹2.0m more than they bought in the last 12 months.
Reported Earnings • Oct 29Second quarter 2024 earnings released: EPS: ₹0.01 (vs ₹0.59 in 2Q 2023)Second quarter 2024 results: EPS: ₹0.01 (down from ₹0.59 in 2Q 2023). Revenue: ₹203.1m (down 37% from 2Q 2023). Net income: ₹83.0k (down 98% from 2Q 2023). Profit margin: 0% (down from 1.6% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 40% per year, which means it is well ahead of earnings.
お知らせ • Oct 19Ritesh International Limited to Report Q2, 2024 Results on Oct 26, 2023Ritesh International Limited announced that they will report Q2, 2024 results on Oct 26, 2023
Buying Opportunity • Sep 07Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.5%. The fair value is estimated to be ₹47.24, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 31% over the last 3 years. Meanwhile, the company became loss making.
お知らせ • Aug 26Ritesh International Limited, Annual General Meeting, Sep 26, 2023Ritesh International Limited, Annual General Meeting, Sep 26, 2023, at 11:00 Indian Standard Time. Location: Momnabad Road, Village Akbarpura, (Ahmedgarh) Sangrur Punjab India Agenda: To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended on March 31, 2023 including Audited Balance Sheet as at March 31, 2023, the Statement of Profit & Loss and Cash Flow Statement for the year ended on that date along with the Reports of the Auditors and Directors thereon; to consider and approve, with or without modification, the appointment of Mr. Rijul Arora, who retires by rotation and being eligible, offers himself for reappointment; and to discuss other business matters.
Reported Earnings • Aug 16First quarter 2024 earnings released: ₹0.15 loss per share (vs ₹1.99 profit in 1Q 2023)First quarter 2024 results: ₹0.15 loss per share (down from ₹1.99 profit in 1Q 2023). Revenue: ₹212.5m (down 57% from 1Q 2023). Net loss: ₹1.29m (down 108% from profit in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 65% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Aug 08Ritesh International Limited to Report Q1, 2024 Results on Aug 14, 2023Ritesh International Limited announced that they will report Q1, 2024 results on Aug 14, 2023
Recent Insider Transactions • Jun 02Additional Non-Executive Director recently sold ₹386k worth of stockOn the 1st of June, Ritesh Arora sold around 9k shares on-market at roughly ₹44.48 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth ₹727k. Insiders have been net sellers, collectively disposing of ₹1.5m more than they bought in the last 12 months.
Valuation Update With 7 Day Price Move • Jun 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹44.36, the stock trades at a trailing P/E ratio of 36x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 1,265% over the past three years.
Reported Earnings • May 27Full year 2023 earnings released: EPS: ₹1.23 (vs ₹4.17 in FY 2022)Full year 2023 results: EPS: ₹1.23 (down from ₹4.17 in FY 2022). Revenue: ₹1.27b (down 9.8% from FY 2022). Net income: ₹10.5m (down 71% from FY 2022). Profit margin: 0.8% (down from 2.5% in FY 2022). Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has increased by 153% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • May 19Ritesh International Limited to Report Q4, 2023 Results on May 25, 2023Ritesh International Limited announced that they will report Q4, 2023 results on May 25, 2023
Valuation Update With 7 Day Price Move • Apr 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹55.39, the stock trades at a trailing P/E ratio of 10.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 1,285% over the past three years.
Valuation Update With 7 Day Price Move • Apr 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹42.21, the stock trades at a trailing P/E ratio of 8.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 560% over the past three years.
Recent Insider Transactions • Mar 08Additional Non-Executive Director recently sold ₹727k worth of stockOn the 6th of March, Ritesh Arora sold around 17k shares on-market at roughly ₹41.57 per share. This transaction amounted to 1.4% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.
Valuation Update With 7 Day Price Move • Feb 28Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹49.40, the stock trades at a trailing P/E ratio of 9.5x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 648% over the past three years.
Valuation Update With 7 Day Price Move • Feb 09Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₹54.00, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 744% over the past three years.
Reported Earnings • Feb 05Third quarter 2023 earnings released: EPS: ₹0.098 (vs ₹0.73 in 3Q 2022)Third quarter 2023 results: EPS: ₹0.098 (down from ₹0.73 in 3Q 2022). Revenue: ₹246.0m (down 32% from 3Q 2022). Net income: ₹840.0k (down 87% from 3Q 2022). Profit margin: 0.3% (down from 1.7% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has increased by 112% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jan 26Ritesh International Ltd to Report Q3, 2023 Results on Feb 02, 2023Ritesh International Ltd announced that they will report Q3, 2023 results at 3:30 PM, Indian Standard Time on Feb 02, 2023
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Non-Executive Independent Director Komal Bhalla was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Nov 11Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₹76.45, the stock trades at a trailing P/E ratio of 13.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 1,811% over the past three years.
Reported Earnings • Nov 06Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: ₹322.9m (down 7.4% from 2Q 2022). Net income: ₹5.06m (up 5.0% from 2Q 2022). Profit margin: 1.6% (up from 1.4% in 2Q 2022). The increase in margin was driven by lower expenses.
お知らせ • Oct 29Ritesh International Ltd to Report Q2, 2023 Results on Nov 04, 2022Ritesh International Ltd announced that they will report Q2, 2023 results on Nov 04, 2022
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 22% share price decline to ₹87.75, the stock trades at a trailing P/E ratio of 15.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 1,387% over the past three years.
Valuation Update With 7 Day Price Move • Sep 13Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹104, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 1,496% over the past three years.
Valuation Update With 7 Day Price Move • Aug 25Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹75.75, the stock trades at a trailing P/E ratio of 13x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 1,126% over the past three years.
お知らせ • Aug 13Ritesh International Ltd, Annual General Meeting, Sep 16, 2022Ritesh International Ltd, Annual General Meeting, Sep 16, 2022, at 11:00 Indian Standard Time. Location: Momnabad Road, Village Akbarpura, (Ahmedgarh) District Sangrur, Punjab -148021 Ahmednagar India Agenda: To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended on March 31, 2022 including Audited Balance Sheet as at March 31, 2022, the Statement of Profit & Loss and Cash Flow Statement for the year ended on that date along with the Reports of the Auditors and Directors thereon; to consider the appointment of Mr. Rajiv Arora, who retires by rotation and being eligible, offers himself for reappointment; to ratify the remuneration payable to the Cost Auditor (Verma Khushwinder & Co.) for the FY 2022-23; and to consider other matters.
お知らせ • Aug 06Ritesh International Ltd to Report Q1, 2023 Results on Aug 12, 2022Ritesh International Ltd announced that they will report Q1, 2023 results at 3:30 PM, Indian Standard Time on Aug 12, 2022
Valuation Update With 7 Day Price Move • Jul 26Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹53.75, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 1,180% over the past three years.
Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹50.80, the stock trades at a trailing P/E ratio of 12.2x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 719% over the past three years.
Valuation Update With 7 Day Price Move • May 19Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹36.10, the stock trades at a trailing P/E ratio of 18.3x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 688% over the past three years.
Buying Opportunity • May 11Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 7.2%. The fair value is estimated to be ₹40.94, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 43% over the last 3 years. Meanwhile, the company has become profitable.
お知らせ • May 10Ritesh International Ltd to Report Q4, 2022 Results on May 18, 2022Ritesh International Ltd announced that they will report Q4, 2022 results on May 18, 2022
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Non-Executive Independent Director Komal Bhalla was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Mar 08Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹31.85, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 314% over the past three years.
Buying Opportunity • Feb 23Now 20% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be ₹37.03, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 43% per annum over the last 3 years. The company has become profitable over the last 3 years.
Board Change • Feb 17Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Non-Executive Independent Director Komal Bhalla was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Jan 03Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹38.15, the stock trades at a trailing P/E ratio of 10.3x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 570% over the past three years.
Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS ₹0.56 (vs ₹0.45 in 2Q 2021)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2022 results: Revenue: ₹348.5m (up 93% from 2Q 2021). Net income: ₹4.82m (up 26% from 2Q 2021). Profit margin: 1.4% (down from 2.1% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has only increased by 48% per year, which means it is significantly lagging earnings growth.
Board Change • Sep 03Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Additional Non-Executive Independent Director Kajal Rai was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Jul 01Full year 2021 earnings released: EPS ₹2.38 (vs ₹0.36 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹748.8m (up 72% from FY 2020). Net income: ₹20.3m (up ₹17.2m from FY 2020). Profit margin: 2.7% (up from 0.7% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jun 18Investor sentiment deteriorated over the past weekAfter last week's 22% share price decline to ₹46.05, the stock trades at a trailing P/E ratio of 13.7x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 208% over the past three years.
Valuation Update With 7 Day Price Move • May 27Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹43.05, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 121% over the past three years.
Valuation Update With 7 Day Price Move • May 04Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹37.05, the stock trades at a trailing P/E ratio of 11.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 173% over the past three years.
Valuation Update With 7 Day Price Move • Apr 08Investor sentiment improved over the past weekAfter last week's 27% share price gain to ₹28.65, the stock trades at a trailing P/E ratio of 8.5x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 160% over the past three years.
Is New 90 Day High Low • Feb 15New 90-day high: ₹14.68The company is up 13% from its price of ₹13.00 on 17 November 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 16% over the same period.
Reported Earnings • Feb 12Third quarter 2021 earnings released: EPS ₹2.48 (vs ₹1.07 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹247.6m (up 102% from 3Q 2020). Net income: ₹21.2m (up 132% from 3Q 2020). Profit margin: 8.6% (up from 7.5% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has only increased by 42% per year, which means it is significantly lagging earnings growth.
お知らせ • Feb 03Ritesh International Ltd to Report Q3, 2021 Results on Feb 10, 2021Ritesh International Ltd announced that they will report Q3, 2021 results on Feb 10, 2021
お知らせ • Dec 13Ritesh International Ltd Announces Appointment of Ritesh Arora as an Additional DirectorRitesh International Ltd. announced that Mr. Ritesh Arora has been appointed by the board as an Additional Director of the company with effect from December 12, 2020.
Valuation Update With 7 Day Price Move • Oct 22Market pulls back on stock over the past weekAfter last week's 16% share price decline to ₹11.40, the stock is trading at a trailing P/E ratio of 12.6x, down from the previous P/E ratio of 14.9x. This compares to an average P/E of 15x in the Chemicals industry in India. Total returns to shareholders over the past three years are 171%.
Valuation Update With 7 Day Price Move • Oct 17Market pulls back on stock over the past weekAfter last week's 17% share price decline to ₹12.86, the stock is trading at a trailing P/E ratio of 14.2x, down from the previous P/E ratio of 17.1x. This compares to an average P/E of 15x in the Chemicals industry in India. Total returns to shareholders over the past three years are 199%.
お知らせ • Oct 13Ritesh International Ltd Announces Retirement of Reeta Challana as an Independent DirectorRitesh International Ltd. announced that at the Annual General Meeting held on September 28, 2020, the shareholders rejected the the resolution of re-appointment of Mrs. Reeta Challana as an independent Director.
お知らせ • Oct 02Ritesh International Ltd Appoints Kajal Rai as Additional Director (Independent Director)Ritesh International Ltd. announced that Ms. Kajal Rai has been appointed by the board as an Additional Director (Independent Director of the company with effect from October 1, 2020.
Is New 90 Day High Low • Sep 30New 90-day high: ₹13.20The company is up 269% from its price of ₹3.58 on 01 July 2020. The Indian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period.
お知らせ • Aug 09Ritesh International Ltd to Report Q1, 2021 Results on Aug 14, 2020Ritesh International Ltd announced that they will report Q1, 2021 results on Aug 14, 2020
お知らせ • Jun 20Ritesh International Ltd to Report Q4, 2020 Results on Jun 26, 2020Ritesh International Ltd announced that they will report Q4, 2020 results on Jun 26, 2020
